
FDA


Breakthrough in the treatment of Huntington’s disease

FDA Grants First Ever Waiver of Clinical Efficacy Studies for Monoclonal Antibody Biosimilar

FDA approves first medication for obstructive sleep apnea: Eli Lilly’s Zepbound GLP-1 agonist

Biocon’s Yesintek receives EMA and FDA approval as the next ustekinumab biosimilar

First-in-class IL-15 superagonist wins FDA approval
